Flexible Ureteroscopy with a Flexible and Navigable Suction Ureteral Access Sheath Versus Mini-Percutaneous Nephrolithotomy for Treatment of 2–3 cm Renal Stones: An International, Multicenter, Randomized, Noninferiority Trial


Zeng G., Jiang K., Liu S., Wu R., Duan X., Chai C. A., ...Daha Fazla

European Urology, 2025 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1016/j.eururo.2025.06.001
  • Dergi Adı: European Urology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, EMBASE, Gender Studies Database, MEDLINE, Nature Index
  • Anahtar Kelimeler: Flexible and navigable suction ureteral access sheath, Flexible ureteroscopy, Percutaneous nephrolithotomy, Renal stones
  • Ankara Üniversitesi Adresli: Evet

Özet

Background and objective: The efficacy and safety of flexible ureteroscopy (f-URS) using a flexible and navigable suction ureteral access sheath (FANS) versus mini-percutaneous nephrolithotomy (mPCNL) for 2–3 cm renal stones remain controversial. Our aim was to conduct a study to address the evidence gap. Methods: We conducted a multicenter, noninferiority, randomized controlled trial in which 720 patients were enrolled across 12 centers in China, Turkey, Russia, India, and Malaysia from August 2024 to February 2025. Patients with 2–3 cm stones were randomized 1:1 to FANS f-URS or mPCNL. The primary outcome was the immediate stone-free rate (SFR) (noninferiority margin −8%). Secondary outcomes included operative time, hospital stay, auxiliary procedures, 3-mo SFR, complications, and quality of life (QoL) improvement. Key findings and limitations: FANS f-URS was noninferior to mPCNL in terms of the immediate SFR (risk difference [RD] −1.4%, 95% confidence interval [CI] −6.7% to 3.9%; noninferiority 1-sided p = 0.007). FANS f-URS had a longer operative time (mean difference [MD] 29 min, 95% CI 24–33; p < 0.001), lower transfusion rate (RD −2.2%, 95% CI −3.9% to −0.5%; p = 0.021), shorter postoperative hospitalization (MD −2.5 d, 95% CI −2.8 to −2.2; p < 0.001), and a greater improvement in QoL score (MD 4.8, 95% CI 3.0–6.6; p < 0.001). We found no evidence of differences in auxiliary procedures, the 3-mo SFR, or infection-related complications. Conclusions and clinical implications: FANS f-URS had a noninferior SFR in comparison to mPCNL for 2–3 cm renal stones, with lower risk of bleeding risk, shorter hospitalization, and superior QoL. These findings support FANS f-URS as a viable alternative to mPCNL for 2–3 cm stones.